Mutations from patients with IPEX ported to mice reveal different patterns of FoxP3 and Treg dysfunction

[1]  C. Benoist,et al.  An interwoven network of transcription factors, with divergent influences from FoxP3, underlies Treg diversity , 2023, bioRxiv.

[2]  A. S. Booeshaghi,et al.  Quantifying orthogonal barcodes for sequence census assays , 2022, bioRxiv.

[3]  A. Rudensky,et al.  The transcription factor FoxP3 can fold into two dimerization states with divergent implications for regulatory T cell function and immune homeostasis. , 2022, Immunity.

[4]  A. Rudensky,et al.  Genetic tracing reveals transcription factor Foxp3-dependent and Foxp3-independent functionality of peripherally induced Treg cells. , 2022, Immunity.

[5]  Jennifer M. Lund,et al.  Mucosal tissue regulatory T cells are integral in balancing immunity and tolerance at portals of antigen entry , 2021, Mucosal Immunology.

[6]  C. Benoist,et al.  FoxP3 associates with enhancer-promoter loops to regulate Treg-specific gene expression , 2021, bioRxiv.

[7]  C. Lareau,et al.  Single-cell chromatin state analysis with Signac , 2021, Nature Methods.

[8]  Bertrand Z. Yeung,et al.  Scalable, multimodal profiling of chromatin accessibility, gene expression and protein levels in single cells , 2021, Nature Biotechnology.

[9]  A. S. Booeshaghi,et al.  Modular, efficient and constant-memory single-cell RNA-seq preprocessing , 2021, Nature Biotechnology.

[10]  Howard Y. Chang,et al.  ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis , 2021, Nature Genetics.

[11]  C. Leslie,et al.  The Transcription Factor Foxp3 Shapes Regulatory T Cell Identity by Tuning the Activity of trans-Acting Intermediaries. , 2020, Immunity.

[12]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[13]  M. Rashid,et al.  IPEX Syndrome with Normal FOXP3 Protein Expression in Treg Cells in an Infant Presenting with Intractable Diarrhea as a Single Symptom , 2020, Case reports in immunology.

[14]  F. Rieux-Laucat,et al.  Single-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrinsic and extrinsic CD4+ T cell perturbations , 2020, Nature Immunology.

[15]  K. Okkenhaug,et al.  BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppression , 2020, The Journal of experimental medicine.

[16]  F. Aghamahdi,et al.  Clinical, immunological, and genetic features in patients with Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) and IPEX-like Syndrome. , 2020, The journal of allergy and clinical immunology. In practice.

[17]  P. Carmeliet,et al.  Functional Reprogramming of Regulatory T cells in the absence of Foxp3 , 2019, Nature Immunology.

[18]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[19]  Howard Y. Chang,et al.  A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells , 2019, Immunity.

[20]  Jason D. Buenrostro,et al.  The cis-Regulatory Atlas of the Mouse Immune System , 2019, Cell.

[21]  F. Rieux-Laucat,et al.  Clinical Heterogeneity of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A French Multicenter Retrospective Study , 2018, Clinical and translational gastroenterology.

[22]  William S. DeWitt,et al.  A Single-Cell Atlas of In Vivo Mammalian Chromatin Accessibility , 2018, Cell.

[23]  Allon M Klein,et al.  Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR , 2018, Nature Immunology.

[24]  Leland McInnes,et al.  UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction , 2018, ArXiv.

[25]  C. Benoist,et al.  FoxP3 scanning mutagenesis reveals functional variegation and mild mutations with atypical autoimmune phenotypes , 2017, Proceedings of the National Academy of Sciences.

[26]  Yizhong Wang,et al.  Atypical Late-Onset Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome with Intractable Diarrhea: A Case Report , 2017, Front. Pediatr..

[27]  F. Rieux-Laucat,et al.  Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study , 2017, The Journal of allergy and clinical immunology.

[28]  C. Benoist,et al.  Different molecular complexes that mediate transcriptional induction and repression by FoxP3 , 2017, Nature Immunology.

[29]  Ryuichi Murakami,et al.  Analyses of a Mutant Foxp3 Allele Reveal BATF as a Critical Transcription Factor in the Differentiation and Accumulation of Tissue Regulatory T Cells , 2017, Immunity.

[30]  William J. Greenleaf,et al.  chromVAR: Inferring transcription factor-associated accessibility from single-cell epigenomic data , 2017, Nature Methods.

[31]  H. Swerdlow,et al.  Large-scale simultaneous measurement of epitopes and transcriptomes in single cells , 2017, Nature Methods.

[32]  C. Benoist,et al.  Flicr, a long noncoding RNA, modulates Foxp3 expression and autoimmunity , 2017, Proceedings of the National Academy of Sciences.

[33]  Fidel Ramírez,et al.  deepTools2: a next generation web server for deep-sequencing data analysis , 2016, Nucleic Acids Res..

[34]  Liza Konnikova,et al.  Individual intestinal symbionts induce a distinct population of RORγ+ regulatory T cells , 2015, Science.

[35]  S. Basu,et al.  T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitis , 2015, Mucosal Immunology.

[36]  A. Rudensky,et al.  Control of the Inheritance of Regulatory T Cell Identity by a cis Element in the Foxp3 Locus , 2014, Cell.

[37]  C. Benner,et al.  Function of a Foxp3 cis-Element in Protecting Regulatory T Cell Identity , 2014, Cell.

[38]  C. Benoist,et al.  Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. , 2014, Immunity.

[39]  J. Stamatoyannopoulos,et al.  Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells , 2014, Nature Immunology.

[40]  B. Stranger,et al.  Interindividual variation in human T regulatory cells , 2014, Proceedings of the National Academy of Sciences.

[41]  B. Chassaing,et al.  Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice , 2014, Current protocols in immunology.

[42]  K. Nakai,et al.  T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. , 2012, Immunity.

[43]  Shane J. Neph,et al.  Foxp3 Exploits a Pre-Existent Enhancer Landscape for Regulatory T Cell Lineage Specification , 2012, Cell.

[44]  C. Benoist,et al.  Treg cells, life history, and diversity. , 2012, Cold Spring Harbor perspectives in biology.

[45]  Scott A. Shaffer,et al.  Transcription factor Foxp3 and its protein partners form a complex regulatory network , 2012, Nature Immunology.

[46]  R. Bacchetta,et al.  Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A Paradigm of Immunodeficiency with Autoimmunity , 2012, Front. Immun..

[47]  S. Ju,et al.  A novel function of IL-2: chemokine/chemoattractant/retention receptor genes induction in Th subsets for skin and lung inflammation. , 2012, Journal of autoimmunity.

[48]  A. Rudensky,et al.  An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes. , 2012, Immunity.

[49]  S. Ziegler,et al.  Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. , 2012, Immunity.

[50]  A. Rudensky,et al.  Regulatory T cells: mechanisms of differentiation and function. , 2012, Annual review of immunology.

[51]  J. Stroud,et al.  Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells. , 2011, Immunity.

[52]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[53]  E. Gambineri,et al.  Point mutants of forkhead box P3 that cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells. , 2010, The Journal of allergy and clinical immunology.

[54]  T. Torgerson,et al.  The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. , 2010, Journal of autoimmunity.

[55]  U. Baron,et al.  Wild-type FOXP3 is selectively active in CD4+CD25(hi) regulatory T cells of healthy female carriers of different FOXP3 mutations. , 2009, Blood.

[56]  C. Benoist,et al.  How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. , 2009, Immunity.

[57]  A. Rudensky,et al.  Differentiation of regulatory Foxp3+ T cells in the thymic cortex , 2008, Proceedings of the National Academy of Sciences.

[58]  Christophe Benoist,et al.  Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. , 2007, Immunity.

[59]  B. Baban,et al.  Role of CD28 in fatal autoimmune disorder in scurfy mice. , 2007, Blood.

[60]  T. Chatila,et al.  Regulatory T cell development in the absence of functional Foxp3 , 2007, Nature Immunology.

[61]  Yuan Shen,et al.  FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression , 2007, Proceedings of the National Academy of Sciences.

[62]  Vincent C. Manganiello,et al.  Foxp3-dependent programme of regulatory T-cell differentiation , 2007, Nature.

[63]  A. Rudensky,et al.  Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice , 2007, Nature Immunology.

[64]  Wayne W. Hancock,et al.  Transcriptional Regulation by Foxp3 Is Associated with Direct Promoter Occupancy and Modulation of Histone Acetylation* , 2006, Journal of Biological Chemistry.

[65]  P. Hass,et al.  Structure of C3b in complex with CRIg gives insights into regulation of complement activation , 2006, Nature.

[66]  P. Chambon,et al.  Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Shimon Sakaguchi,et al.  Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. , 2006, International immunology.

[68]  J. Stroud,et al.  FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT , 2006, Cell.

[69]  S. Ziegler,et al.  Defective regulatory and effector T cell functions in patients with FOXP3 mutations. , 2006, The Journal of clinical investigation.

[70]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[71]  A. Rudensky,et al.  Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[72]  T. Chatila,et al.  Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. , 2005, The Journal of allergy and clinical immunology.

[73]  E. Bettelli,et al.  Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[74]  G. Freeman,et al.  CD4 CD25 T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion , 2004 .

[75]  A. Filipovich,et al.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome , 2002, Journal of medical genetics.

[76]  S. Ziegler,et al.  Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation* , 2001, The Journal of Biological Chemistry.

[77]  H. Mcdevitt,et al.  The role of MHC class II molecules in susceptibility and resistance to autoimmunity. , 1998, Current opinion in immunology.

[78]  C. Benoist,et al.  Checkpoints in the progression of autoimmune disease: lessons from diabetes models. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[79]  L. Wicker,et al.  Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse , 1987, The Journal of experimental medicine.

[80]  H. Mcdevitt,et al.  The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Y. Hayashi,et al.  Genetic analysis for insulitis in NOD mice. , 1985, Jikken dobutsu. Experimental animals.

[82]  B. Powell,et al.  An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. , 1982, The Journal of pediatrics.

[83]  Y. Tochino,et al.  Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.

[84]  H. Ochs,et al.  Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome , 2018, Front. Immunol..

[85]  L. Wen,et al.  The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes. , 2016, Journal of autoimmunity.

[86]  A. Freitas,et al.  IPEX and FOXP3: clinical and research perspectives. , 2005, Journal of autoimmunity.

[87]  J. Casanova,et al.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.